The relative values of salicylate or steroid (in conjunction with bed rest and penicillin therapy) in rheumatic fever continue to be controversial. Thus Massell et al. (1961) found that. on the whole, patients treated with hormone subsequently did better than those given salicylate or no specific antirheumatic therapy as regards the disappearance of significant murmurs, yet Friedman et al. (1962) found no beneficial effect.
We have previously published our findings on the course of rheumatic fever in hospital in two series of cases-one treated by bed rest and the other by six-week courses of A.C.T.H., cortisone, or salicylate in the U.K.-U.S. Co-operative Trial (Bywaters and Thomas, 1961 ; U.K.-U.S. Trial, 1955) . We concluded that most cases of rheumatic fever responded to bed rest alone and that, though salicylates bring about symptomatic relief, they do not significantly alter the course of the disease or have any effect on cardiac status. Steroids had no demonstrable beneficial effect on the heart in most cases except possibly in the disappearance of soft diastolic murmurs, and this was shown in a later paper to have little effect on the findings five years later (Thomas, 1961) . They were, however, indicated in cases with cardiac enlargement and activity, for by suppressing the rheumatic activity they diminished the risk of failure. Also, they were useful in patients with established failure and activity; for after the activity had been controlled the failure responded to drugs such as digitalis and mersalyl. The conclusion of the analysis of all cases treated in the Co-operative Trial at the end of one and five years was that cortisone and A.C.T.H. had no advantage over salicylate, and we found little difference in end-results between our cases treated by bed rest and those treated in this trial.
A criticism of the treatment in the Co-operative Trial has been that the six-week courses were too short, and that had longer ones been used 
Recurrences
Two of the 46 in the third series who were seen at five years had recurrences during this period, as did 3 out of 54 in the U.K. trial. Thus the recurrence rate in the two series, both of which had been on prophylaxis (sulphonamides in the U.K. trial and penicillin in the third series) was low-4% (2 out of 46) in the third and 5.5% (3 out of 54) in the U.K. trial. No case in either series had more than one recurrence and none was worse after them. In the bed-rest series who were not given prophylaxis, on the other hand, recurrences were more common-in 9 out of 107 admitted in first attacks (8.4%)-there was sometimes more than one recurrence and two of the nine patients with recurrences were worse after them.
Thus the only difference at five-year follow-up between these three series of cases was that the recurrence rate had been higher in the bed-rest, nonprotected group than in the other two, and some cases in this group who had recurrences were worse after them whereas there was no deterioration after recurrences in the other two: without recurrences there was no difference between the three groups. Thus the cardiac status at five years did not appear to be influenced by treatment in hospital with cortisone or salicylate even in the higher dosage used in the third series, but it did appear to be improved in those cases where prophylaxis had been used.
Discussion
While this disease is on the wane in regard to both incidence and severity in the more prosperous countries, it is still a major problem in many parts of the world and particularly in crowded areas with a low standard of living. A major advance has been made in the field of prevention both of first attacks and of recurrent attacks. Modern treatment does not seem otherwise to be greatly in advance of that which was known to our fathers, except possibly in severe cases with carditis and heart failure. Here it seems likely that some amelioration is feasible, but because of the rarity of such cases in countries such as this it is difficult to prove on a controlled basis. As has been previously stated, " the major factor in determining the incidence of rheumatic heart disease at the end of five years is the status of the heart at the time treatment was begun" had been on cortisone. There were too few cases in No difference was noted between the two treatment groups in the development or disappearance of significant murmurs during the stay in hospital, nor was there any difference between them at five-year follow-up.
The series has been compared with another comprising similar cases that were treated with six-week courses of A.C.T.H., cortisone, or aspirin in the U.K.-U.S. Co-operative Clinical Trial. No difference was apparent between them either in hospital or at five-year follow-up.
Thus prolonged (12 weeks) courses of cortisone or aspirin as used in the present series had no advantage over the shorter one used in the Co-operative Clinical Trial and cortisone had none over salicylate.
Excluding patients with recurrences during the fiveyear follow-up period, those who had been treated here with bed rest and given no specific antirheumatic treatment or prophylaxis did as well during this five-year period as those in the Co-operative Trial and the recent series who were on prophylaxis. However, with recurrences the bed-rest non-protected group fared less well; recurrences were more common and many were worse after them.
Prophylaxis is still, therefore, the most effective way we have of reducing the severity of residual heart disease, and there is as yet no evidence that steroid is of value in this regard.
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"The [Royal College of] Physicians' report on the relationship between smoking and lung cancer has had an appreciably greater initial impact on tobacco consumption than was generally supposed.
Several weeks after the report was released it was widely estimated that cigarette sales had fallen by about 10 per cent. But withdrawals of tobacco from bond for home consumption (which to all intents and purposes are the same as sales to the public in normal times) fell by over 18 per cent in April, the first full month after the report was issued. The precise figures were 17,122,000 lb. in April this year compared with 21,155,000 lb. in April, 1961. Prior to the report, withdrawals were only slightly less than those for a year earlier.
Thus it is fair to assume that virtually all of the April drop was directly attributable to the Physicians' report and the publicity it received, though part of it may have reflected a runnning down of stocks on retailers' shelves. Recent statements from the trade indicate that the public has already recovered from the shock.
Estimates now suggest that cigarette consumption is now no more than 5 
